(S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (JJ novel) (NN method)) (S (VP (TO to) (ADVP (RB successfully)) (VP (VB detect) (NP (DT the) (NNS ADRs)) (S (VP (VBG using) (NP (NP (NN feature) (NN matrix)) (CC and) (NP (NN feature) (NN selection))))))))) (. .))
(S (NP (NP (DT A) (NN feature) (NN matrix)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ characterizes) (NP (NP (DT the) (JJ medical) (NNS events)) (SBAR (SBAR (IN before) (S (NP (NNS patients)) (VP (VBP take) (NP (NNS drugs))))) (CC or) (SBAR (IN after) (S (NP (NNS patients)) (VP (VBP take) (NP (NNS drugs)))))))))) (, ,)) (VP (VBZ is) (VP (VBN created) (PP (IN from) (NP (JJ THIN) (NN database))))) (. .))
(S (NP (NP (DT The) (NN feature) (NN selection) (NN method)) (PP (IN of) (NP (NP (NNP Student) (POS 's)) (NN t) (HYPH -) (NN test)))) (VP (VBZ is) (VP (VBN used) (S (VP (TO to) (VP (VB detect) (NP (DT the) (JJ significant) (NNS features)) (PP (IN from) (NP (NP (NNS thousands)) (PP (IN of) (NP (JJ medical) (NNS events)))))))))) (. .))
(S (NP (NP (DT The) (JJ significant) (NNS ADRs)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBG corresponding) (PP (IN to) (NP (JJ significant) (NNS features))))))) (, ,)) (VP (VBP are) (VP (VBN detected))) (. .))
(S (NP (NNS Experiments)) (VP (VBP are) (VP (VBN performed) (PP (IN on) (NP (DT the) (NN drug) (NN Pioglitazone))))) (. .))
(S (PP (VBN Compared) (PP (IN to) (NP (JJ other) (JJ computerized) (NNS methods)))) (, ,) (NP (PRP$ our) (JJ proposed) (NN method)) (VP (VBZ achieves) (NP (JJ good) (NN performance))) (. .))
